Tradewinds Capital Management’s Idexx Laboratories IDXX Stock Holding History

Tradewinds Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.74K	Hold	9	–	–	﹤0.01%	478
2026 Q1	$5.06K	Hold	9	–	–	﹤0.01%	463
2025 Q4	$6.09K	Hold	9	–	–	﹤0.01%	431
2025 Q3	$5.75K	Hold	9	–	–	﹤0.01%	424
2025 Q2	$4.83K	Hold	9	–	–	﹤0.01%	414
2025 Q1	$3.78K	Hold	9	–	–	﹤0.01%	439
2024 Q4	$3.72K	Hold	9	–	–	﹤0.01%	453
2024 Q3	$4.55K	Hold	9	–	–	﹤0.01%	413
2024 Q2	$4.38K	Hold	9	–	–	﹤0.01%	390
2024 Q1	$4.86K	Hold	9	–	–	﹤0.01%	362
2023 Q4	$5K	Hold	9	–	–	﹤0.01%	286
2023 Q3	$3.94K	Hold	9	–	–	﹤0.01%	299
2023 Q2	$4.52K	Buy	+9	New	+$4.31K	﹤0.01%	285
2018 Q3	–	Sell	-2	Closed	–	–	658
2018 Q2	$0	Hold	2	–	–	﹤0.01%	660
2018 Q1	$0	Hold	2	–	–	﹤0.01%	679
2017 Q4	$0	Buy	+2	New	+$315	﹤0.01%	713
2017 Q1	–	Sell	-85	Closed	-$10K	–	698
2016 Q4	$10K	Buy	+85	New	+$9.7K	0.01%	376

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Tradewinds Capital Management's IDXX Position: Q2 2026 in Review

Tradewinds Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 9 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

Tradewinds Capital Management first reported a position in IDXX in Q4 2016 and has held it in 17 quarters since. The position peaked at $10K in Q4 2016. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Tradewinds Capital Management held 9 shares of Idexx Laboratories worth $4.74K as of Q2 2026.
Tradewinds Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #478 holding.
Tradewinds Capital Management first reported a position in Idexx Laboratories in Q4 2016 and has held it in 17 quarters since.
Tradewinds Capital Management's Idexx Laboratories position peaked at $10K in Q4 2016.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.